Insider Cluster (2 insiders) ·Filed Aug 18, 2026

JNJ

JOHNSON & JOHNSON
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago
Insider cluster: 2 insiders, $30.7M total
Actionable Insight • Neutral

The insider sales are mechanically linked to option exercises and are immaterial relative to JNJ's market cap. No bearish signal. Monitor for any future open-market purchases by C-suite as a more meaningful signal of conviction. The next quarterly earnings (expected late October) will be the primary catalyst for JNJ shares.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
JNJ ▼ -1.17% at T+20d
NEUTRAL call ✗ call lost -1.17% · α vs SPY +0.79% · entry $273.41 → $270.22
Next anchor: T+60d in 6w
Latest observation: T+28 -4.94% FF3 residual α
Entry anchored
Aug 18, 05:47 PM ET
via 1-min bar
T+1d
-2.21%
call -2.21% · α -1.37%
$267.37
settled 6w ago
T+5d
-1.25%
call -1.25% · α -0.86%
$270.00
settled 5w ago
T+20d
-1.17%
call -1.17% · α +0.79%
$270.22
settled 16d ago
T+60d
—
call — · α —
—
in 6w

Price Chart

Loading chart...

Executive Summary

CEO Joaquin Duato and EVP Jennifer Taubert sold a combined $30.65M in open-market stock over a 5-day window, with Duato's $32.2M sale being the dominant event. The sales are tied to derivative exercises (Duato exercised 123,291 options at $115.67/share, Taubert exercised 15,000 options at $115.67/share), which is a routine pattern for tax and diversification purposes. At $632.3B market cap, the total open-market sales represent ~0.005% of market cap — a trivial amount that does not signal a bearish view on the company's prospects. The cluster is neutral, as the dollar value is immaterial relative to company size and the sales are mechanically linked to option exercises.

Key Financial Metrics

Direction
selling
Total Value
$30.6M
Insiders
2

Key Facts

  • CEO Joaquin Duato sold 123,291 shares in open-market transactions for ~$32.2M on 2026-08-13, concurrent with exercising 123,291 options at $115.67/share
  • EVP Jennifer Taubert sold 15,000 shares for ~$3.95M on 2026-08-17, concurrent with exercising 15,000 options at $115.67/share
  • Total open-market sales: $30.65M, representing ~0.005% of JNJ's $632.3B market cap
  • Both sales are directly tied to derivative exercises — a routine pattern for tax withholding and portfolio diversification, not a bearish signal
  • No open-market purchases in the cluster; all activity is sell-side and option-exercise-driven

Financial Impact

Total open-market sales of $30.65M represent ~0.005% of JNJ's $632.3B market cap — economically trivial

insider ownership

Risk Factors

  • Insider sales could be misinterpreted as bearish by algorithmic trading systems
  • CEO selling near all-time-high stock price (~$271) may create negative sentiment among retail investors
  • No insider buying to offset the selling pattern

Market Snapshot

Price
$271.11
Volume
200
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
71% bullish (31 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-JNJ-1787092304730
16 reports for JNJ
Performance horizon
60% Hit rate 3 of 5 directional calls best @ T+60▲ +13.24%May 13, 2026
Filters
Rows
Reports for JNJ — sortable, filterable
TypeNow
Sep 9, 2026
23d ago
Court Ruling
NEUTRAL ★ 1/10
$267.08 $267.28▲ +0.07%▲ +0.73%$258.66 (−3.15%)
Aug 18, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$273.41 $270.00▼ −1.25%▼ −0.86%$258.66 (−5.39%)
Aug 14, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$260.35 $270.24▲ +3.80%▲ +5.17%$258.66 (−0.65%)
Aug 7, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$261.81 $262.37▲ +0.21%▲ +0.26%$258.66 (−1.20%)
Aug 7, 2026
8w ago
Court Ruling
BEARISH ★ 4/10
$259.24 $260.35▼ −0.43%▼ −0.03%$258.66 (+0.22%)
Aug 4, 2026
8w ago
8-K
NEUTRAL ★ 2/10
$254.93 $259.80▲ +1.91%▲ +2.01%$258.66 (+1.46%)
Jul 22, 2026
10w ago
Court Ruling
BEARISH ★ 7/10
$255.63 $265.53▼ −3.87%▼ −6.27%$258.66 (−1.19%)
Jul 15, 2026
11w ago
8-K
BULLISH ★ 6/10
$247.02 $255.63▲ +3.49%▲ +4.47%$258.66 (+4.71%)
May 20, 2026
19w ago
Court Ruling
NEUTRAL ★ 1/10
$229.12 $231.29▲ +0.95%▼ −0.29%$258.66 (+12.89%)
May 13, 2026
20w ago
ANALYST-UPGRADE
BULLISH ★ 3/10
$230.79 $231.58▲ +0.34%▲ +1.06%$258.66 (+12.08%)
Showing 10 of 16

US Market Status

Market Closed — Opens in 3m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 18, 2026